If the filing person has previously filed a statement on Schedule 13G to
report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13(d)-1(f)
or 240.13d-1(g), check the following box. ☐
| CUSIP No. 294100102 |
13D |
Page 2 of 5 Pages |
| 1. |
NAME OF REPORTING PERSONS
I.R.S. IDENTIFICATION NO. OF ABOVE PERSON (ENTITIES ONLY):
James G. Wolf
|
| 2. |
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) o
(b) o |
| 3. |
SEC USE ONLY
|
| 4. |
SOURCE OF FUNDS *
PF |
| 5. |
CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS
2(d) or 2(e)
o |
| 6. |
CITIZENSHIP OR PLACE OF ORGANIZATION:
U.S.A. |
| NUMBER
OF |
7. |
SOLE
VOTING POWER |
| SHARES |
|
3,698,500 |
| BENEFICIALLY |
8. |
SHARED
VOTING POWER |
| OWNED
BY |
|
470,000 |
| EACH |
9. |
SOLE
DISPOSITIVE POWER |
| REPORTING |
|
3,698,500 |
| PERSON |
10. |
SHARED
DISPOSITIVE POWER |
| WITH |
|
470,000 |
| 11. |
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON:
4,168,500 |
| 12. |
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN
SHARES*
o |
| 13. |
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 11:
8.56% |
| 14. |
TYPE OF REPORTING PERSON
IN |
| |
|
|
|
| CUSIP No. 294100102 |
13D |
Page 3 of 5 Pages |
EXPLANATORY NOTE
This Amendment No. 3 (the "Amendment") amends the statement on
Schedule 13D originally filed by James G. Wolf on October 1, 2021 to provide additional information to update Amendment No. 2 and disclose
Mr. Wolf's beneficial ownership of the Common Stock of Enzo Biochem, Inc. and other derivative/option holdings as of November 22, 2022.
Item 1. Security and Issuer
The class of equity securities to which this Schedule 13D relates is the
Common Stock, $0.01 par value, (the "Common Stock") of Enzo Biochem, Inc., a New York corporation (the "Company").
The principal executive offices of the Company are located at 81 Executive Blvd., Suite 3, Farmingdale, New York 11735.
Item 2. Identity and Background
| b. | Business
Address: 105, Flyway Drive, Kiawah Island, SC 29455 |
| c. | Present
employment: Self. |
| d. | During
the past five years, James G. Wolf has not been convicted in any criminal proceeding. |
| e. | During
the past five years, James G. Wolf has not been a party to any civil proceeding of a judicial
or administrative body of competent jurisdiction as a result of which he was subject to any
judgment, decree or final order enjoining future violations of, or prohibiting or mandating
activities subject to, federal or state securities laws or finding any violation with respect
to such laws. |
Item 3. Source and Amount of Funds or Other Consideration.
The cash used to acquire the shares (a total of $13,287,539) was sourced
from the personal funds of the Reporting Person, from $405,403 of premiums received from the sale of put options, and from the personal
funds of certain persons with respect to whose shares the Reporting Person holds voting power and dispositive power. The cash used to
acquire the call options (an additional $287,623) was also sourced from the personal funds of the Reporting Person.
Item 4. Purpose of Transaction.
The Reporting Person has no plan or proposal which
relates to or would result in any of the actions or transactions described in paragraphs (a) through (j) of the instructions to Item
4 of Schedule 13D, except that the Reporting Person may nominate himself for election as a director of the Company at the next annual
meeting of shareholders if he is not nominated by the Board of Directors.
Item 5. Interest in Securities of the Issuer.
(a) The information regarding share ownership by the
Reporting Person provided on his cover page is incorporated here by reference.
(b) The information regarding share ownership by the
Reporting Person provided on his cover page is incorporated here by reference.
(c) Schedule A
annexed hereto lists all transactions in securities of the Issuer by the Reporting Person during the past 60 days and since August 2,
2022. All such transactions were effected in the open market.
(d) The right to receive dividends
and to receive the proceeds of the sale of the securities is held, as to 470,000 of the shares, by persons other than the Reporting Person.
(e) Not applicable.
Item 6. Contracts, Arrangements, Understandings or Relationships
There are no contracts, arrangements, understandings or relationships (legal
or otherwise) between the Reporting Person named in Item 2 hereof and any person with respect to any securities of the Company, including
but not limited to transfer or voting of any other securities, finder's fees, joint ventures, loan or option arrangements, puts or calls,
guarantees of profits, divisions of profits or loss, or the giving or withholding of proxies, except as follows:
The Reporting Person owns 8,507 publicly-traded call options
to purchase 850,700 shares of the Common Stock. The options expire in January 2023 and April 2023 and have strike prices ranging from
$2.50 to $7.50.
The Reporting Person has sold 6,995 publicly-traded put options
pursuant to which a total of 699,500 shares of the Common Stock may be sold to him. The options expire in January 2023 or April 2023
and have exercise prices ranging from $2.50 to $5.00.
Item 7. Material to be Filed as Exhibits.
None.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete and correct.
| Dated: November 23, 2022 |
/s/ James G. Wolf |
| |
James G. Wolf |
| CUSIP No. 294100102 |
13D |
Page
4 of 5 Pages
|
SCHEDULE A
Transactions in the Securities of the Issuer
Since August 2, 2022
| Nature
of Transaction |
Amount
of Securities Purchased |
Average
Price ($) Per Share |
Date
of Purchase |
| Purchase
of Common Stock |
18,100 |
2.50 |
8/2/2022 |
| Purchase
of Common Stock |
21,000 |
2.89 |
8/4/2022 |
| Purchase
of Common Stock |
9,900 |
2.53 |
8/5/2022 |
| Purchase
of Common Stock |
6,400 |
2.51 |
8/9/2022 |
| Purchase
of Common Stock |
17,933 |
2.57 |
8/10/2022 |
| Purchase
of Common Stock |
2,100 |
2.69 |
8/12/2022 |
| Purchase
of Common Stock |
2,800 |
2.67 |
8/17/2022 |
| Purchase
of Common Stock |
2,200 |
2.55 |
8/18/2022 |
| Purchase
of Common Stock |
19,827 |
2.59 |
8/19/2022 |
| Purchase
of Common Stock |
1,267 |
2.57 |
8/24/2022 |
| Purchase
of Common Stock |
38,576 |
4.55 |
8/25/2022 |
| Purchase
of Common Stock |
12,500 |
2.47 |
8/31/2022 |
| Purchase
of Common Stock |
1,300 |
5.00 |
9/1/2022 |
| Purchase
of Common Stock |
6,200 |
2.44 |
9/2/2022 |
| Purchase
of Common Stock |
35,390 |
4.18 |
9/6/2022 |
| Purchase
of Common Stock |
8,804 |
2.22 |
9/7/2022 |
| Purchase
of Common Stock |
14,369 |
2.23 |
9/8/2022 |
| Purchase
of Common Stock |
5,000 |
2.30 |
9/9/2022 |
| Purchase
of Common Stock |
3,737 |
2.23 |
9/15/2022 |
| Purchase
of Common Stock |
500 |
7.50 |
9/16/2022 |
| Purchase
of Common Stock |
9,351 |
2.49 |
9/19/2022 |
| Purchase
of Common Stock |
484 |
2.27 |
9/20/2022 |
| Purchase
of Common Stock |
1,860 |
2.27 |
9/21/2022 |
| Purchase
of Common Stock |
2,734 |
2.25 |
9/22/2022 |
| Purchase
of Common Stock |
26,571 |
3.18 |
9/23/2022 |
| Purchase
of Common Stock |
10,700 |
5.00 |
9/26/2022 |
| Purchase
of Common Stock |
300 |
2.18 |
9/28/2022 |
| Purchase
of Common Stock |
25,000 |
2.19 |
9/29/2022 |
| Purchase
of Common Stock |
20,000 |
2.29 |
10/6/2022 |
| Purchase
of Common Stock |
3,000 |
5.00 |
10/7/2022 |
| Purchase
of Common Stock |
2,000 |
2.10 |
10/11/2022 |
| Purchase
of Common Stock |
11,700 |
5.00 |
10/12/2022 |
| Purchase
of Common Stock |
26,900 |
2.49 |
10/14/2022 |
| Purchase
of Common Stock |
1,000 |
2.10 |
10/17/2022 |
| Purchase
of Common Stock |
17,632 |
2.17 |
10/18/2022 |
| Purchase
of Common Stock |
81,150 |
4.94 |
10/19/2022 |
| CUSIP No. 294100102 |
13D |
Page 5 of 5 Pages |
| Purchase
of Common Stock |
30,778 |
2.48 |
10/20/2022 |
| Purchase
of Common Stock |
104,224 |
3.63 |
10/21/2022 |
| Purchase
of Common Stock |
4,116 |
2.23 |
10/24/2022 |
| Purchase
of Common Stock |
21,000 |
2.14 |
10/31/2022 |
| Purchase
of Common Stock |
6,101 |
2.14 |
11/1/2022 |
| Purchase
of Common Stock |
2,399 |
2.14 |
11/3/2022 |
| Purchase
of Common Stock |
300 |
2.50 |
11/16/2022 |
| Purchase
of Common Stock |
24,700 |
2.50 |
11/18/2022 |